The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
A diverse range of gene products are effectors of the type I interferon antiviral response
Open accessAbstract
The type I interferon response protects cells against invading viral pathogens. The cellular factors that mediate this defence are the products of interferon-stimulated genes (ISGs). Although hundreds of ISGs have been identified since their discovery more than 25 years ago, only a few have been characterized with respect to antiviral activity. For most ISG products, little is known about their antiviral potential, their target specificity and their mechanisms of action. Using an overexpression screening approach, here we show that different viruses are targeted by unique sets of ISGs. We find that each viral species is susceptible to multiple antiviral genes, which together encompass a range of inhibitory activities. To conduct the screen, more than 380 human ISGs were tested for their ability to inhibit the replication of several important human and animal viruses, including hepatitis C virus, yellow fever virus, West Nile virus, chikungunya virus, Venezuelan equine encephalitis virus and human immunodeficiency virus type-1. Broadly acting effectors included IRF1, C6orf150 (also known as MB21D1), HPSE, RIG-I (also known as DDX58), MDA5 (also known as IFIH1) and IFITM3, whereas more targeted antiviral specificity was observed with DDX60, IFI44L, IFI6, IFITM2, MAP3K14, MOV10, NAMPT (also known as PBEF1), OASL, RTP4, TREX1 and UNC84B (also known as SUN2). Combined expression of pairs of ISGs showed additive antiviral effects similar to those of moderate type I interferon doses. Mechanistic studies uncovered a common theme of translational inhibition for numerous effectors. Several ISGs, including ADAR, FAM46C, LY6E and MCOLN2, enhanced the replication of certain viruses, highlighting another layer of complexity in the highly pleiotropic type I interferon system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Virus interference. I. the interferon
Isaacs, A., & Lindenmann, J. (1957) · Proceedings of the Royal Society of London. Series B - Biological Sciences · doi:10.1098/rspb.1957.0048 · Cited by 3,451
Complete Replication of Hepatitis C Virus in Cell Culture
Lindenbach, B. D., Evans, M. J., Syder, A. J., Wölk, B., Tellinghuisen, T. L., Liu, C. C., Maruyama, T., Hynes, R. O., Burton, D. R., McKeating, J. A., et al. (2005) · Science · doi:10.1126/science.1114016 · Cited by 2,238
Self-citationBrass, A. L., Huang, I.-C., Benita, Y., John, S. P., Krishnan, M. N., Feeley, E. M., Ryan, B. J., Weyer, J. L., van der Weyden, L., Fikrig, E., et al. (2009) · Cell · doi:10.1016/j.cell.2009.12.017 · Cited by 1,269
Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry
Evans, M. J., von Hahn, T., Tscherne, D. M., Syder, A. J., Panis, M., Wölk, B., Hatziioannou, T., McKeating, J. A., Bieniasz, P. D., & Rice, C. M. (2007) · Nature · doi:10.1038/nature05654 · Cited by 1,232
Self-citationHighly Permissive Cell Lines for Subgenomic and Genomic Hepatitis C Virus RNA Replication
Blight, K. J., McKeating, J. A., & Rice, C. M. (2002) · Journal of Virology · doi:10.1128/jvi.76.24.13001-13014.2002 · Cited by 1,193
Self-citationFunctional classification of interferon-stimulated genes identified using microarrays
de Veer, M. J., Holko, M., Frevel, M., Walker, E., Der, S., Paranjape, J. M., Silverman, R. H., & Williams, B. R. G. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.6.912 · Cited by 900
HIV-1 Genome Nuclear Import Is Mediated by a Central DNA Flap
Zennou, V., Petit, C., Guetard, D., Nerhbass, U., Montagnier, L., & Charneau, P. (2000) · Cell · doi:10.1016/s0092-8674(00)80828-4 · Cited by 833
Impaired response to interferon-α/β and lethal viral disease in human STAT1 deficiency
Dupuis, S., Jouanguy, E., Al-Hajjar, S., Fieschi, C., Al-Mohsen, I. Z., Al-Jumaah, S., Yang, K., Chapgier, A., Eidenschenk, C., Eid, P., et al. (2003) · Nature Genetics · doi:10.1038/ng1097 · Cited by 816
Viral evasion and subversion of pattern-recognition receptor signalling
Bowie, A. G., & Unterholzner, L. (2008) · Nature Reviews Immunology · doi:10.1038/nri2436 · Cited by 746
Interferon signaling and treatment outcome in chronic hepatitis C
Sarasin-Filipowicz, M., Oakeley, E. J., Duong, F. H. T., Christen, V., Terracciano, L., Filipowicz, W., & Heim, M. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707882105 · Cited by 642
Isaacs, A., & Lindenmann, J. (2015) · The Journal of Immunology · doi:10.1093/jimmunol/195.5.1911 · Cited by 602
Interferon signalling network in innate defence
Takaoka, A., & Yanai, H. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00716.x · Cited by 581
Recognition of viruses by cytoplasmic sensors
Wilkins, C., & Gale, M. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.12.003 · Cited by 430
Expression of the Zinc-Finger Antiviral Protein Inhibits Alphavirus Replication
Bick, M. J., Carroll, J.-W. N., Gao, G., Goff, S. P., Rice, C. M., & MacDonald, M. R. (2003) · Journal of Virology · doi:10.1128/jvi.77.21.11555-11562.2003 · Cited by 384
Self-citationtrans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication
Lindenbach, B. D., & Rice, C. M. (1997) · Journal of Virology · doi:10.1128/jvi.71.12.9608-9617.1997 · Cited by 374
Self-citationReal-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system
Jones, C. T., Catanese, M. T., Law, L. M. J., Khetani, S. R., Syder, A. J., Ploss, A., Oh, T. S., Schoggins, J. W., MacDonald, M. R., Bhatia, S. N., et al. (2010) · Nature Biotechnology · doi:10.1038/nbt.1604 · Cited by 249
Self-citationInterferon Action in Triply Deficient Mice Reveals the Existence of Alternative Antiviral Pathways
Zhou, A., Paranjape, J. M., Der, S. D., Williams, B. R. G., & Silverman, R. H. (1999) · Virology · doi:10.1006/viro.1999.9738 · Cited by 244
Transcriptional induction of two genes in human cells by beta interferon.
Larner, A. C., Jonak, G., Cheng, Y. S., Korant, B., Knight, E., & Darnell, J. E. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.21.6733 · Cited by 225
Infectious Clones of Chikungunya Virus (La Réunion Isolate) for Vector Competence Studies
Tsetsarkin, K., Higgs, S., McGee, C. E., Lamballerie, X. D., Charrel, R. N., & Vanlandingham, D. L. (2006) · Vector-Borne and Zoonotic Diseases · doi:10.1089/vbz.2006.6.325 · Cited by 209
Kuchta, K., Knizewski, L., Wyrwicz, L. S., Rychlewski, L., & Ginalski, K. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp854 · Cited by 199
Human Immunodeficiency Virus, Restriction Factors, and Interferon
Neil, S. J. D., & Bieniasz, P. D. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2009.0077 · Cited by 168
Self-citationIdentification of Genes Selectively Regulated by IFNs in Endothelial Cells
Indraccolo, S., Pfeffer, U., Minuzzo, S., Esposito, G., Roni, V., Mandruzzato, S., Ferrari, N., Anfosso, L., Dell’Eva, R., Noonan, D. M., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.2.1122 · Cited by 158
Control of the Interferon-Induced 68-Kilodalton Protein Kinase by the HIV-1 tat Gene Product
Roy, S., Katze, M. G., Parkin, N. T., Edery, I., Hovanessian, A. G., & Sonenberg, N. (1990) · Science · doi:10.1126/science.2180064 · Cited by 153
Toth, A. M., Li, Z., Cattaneo, R., & Samuel, C. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.045146 · Cited by 151
Petrakova, O., Volkova, E., Gorchakov, R. V., Paessler, S., Kinney, R. M., & Frolov, I. V. (2005) · Journal of Virology · doi:10.1128/jvi.79.12.7597-7608.2005 · Cited by 150
Editing of HIV-1 RNA by the double-stranded RNA deaminase ADAR1 stimulates viral infection
Doria, M., Neri, F., Gallo, A., Farace, M. G., & Michienzi, A. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp604 · Cited by 144
Leaman, D. W., Chawla‐Sarkar, M., Jacobs, B., Vyas, K., Sun, Y., Ozdemir, A. M., Yi, T., Williams, B. R. G., & Borden, E. C. (2003) · Journal of Interferon & Cytokine Research · doi:10.1089/107999003772084860 · Cited by 124
Differential Responses to IFN-α Subtypes in Human T Cells and Dendritic Cells
Hilkens, C. M. U., Schlaak, J., & Kerr, I. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.10.5255 · Cited by 115
Lanford, R. E., Guerra, B., Lee, H., Chavez, D., Brasky, K. M., & Bigger, C. B. (2006) · Hepatology · doi:10.1002/hep.21167 · Cited by 114
Impaired Antiviral Response in Human Hepatoma Cells
Keskinen, P., Nyqvist, M., Sareneva, T., Pirhonen, J., Melén, K., & Julkunen, I. (1999) · Virology · doi:10.1006/viro.1999.9983 · Cited by 113
Perturbation of the P-Body Component Mov10 Inhibits HIV-1 Infectivity
Furtak, V. A., Mulky, A., Rawlings, S. A., Kozhaya, L., Lee, K., KewalRamani, V. N., & Unutmaz, D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009081 · Cited by 111
Zhang, Y., Hatziioannou, T., Zang, T. M., Braaten, D. C., Luban, J., Goff, S. P., & Bieniasz, P. D. (2002) · Journal of Virology · doi:10.1128/jvi.76.12.6332-6343.2002 · Cited by 108
Self-citationInterferons induce an antiviral state in human pancreatic islet cells
Hultcrantz, M., Hühn, M. H., Wolf, M., Olsson, A., Jacobson, S., Williams, B. R., Korsgren, O., & Flodström-Tullberg, M. (2007) · Virology · doi:10.1016/j.virol.2007.05.010 · Cited by 98
He, X.-S., Ji, X., Hale, M. B., Cheung, R. C., Ahmed, A., Guo, Y., Nolan, G. P., Pfeffer, L. M., Wright, T. L., RISCH, N. J., et al. (2006) · Hepatology · doi:10.1002/hep.21267 · Cited by 87
A ChIP–chip approach reveals a novel role for transcription factor IRF1 in the DNA damage response
Frontini, M., Vijayakumar, M., Garvin, A. J., & Clarke, N. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn1051 · Cited by 69
Liu, H., Niikura, M., Fulton, J. E., & Cheng, H. H. (2003) · Cytogenetic and Genome Research · doi:10.1159/000075767 · Cited by 61
Novel interferon-β-induced gene expression in peripheral blood cells
Rani, M. R. S., Shrock, J., Appachi, S., Rudick, R. A., Williams, B. R. G., & Ransohoff, R. M. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0507273 · Cited by 48
McGee, C. E., Shustov, A. V., Tsetsarkin, K. A., Frolov, I. V., Mason, P. W., Vanlandingham, D. L., & Higgs, S. (2009) · Vector-Borne and Zoonotic Diseases · doi:10.1089/vbz.2009.0067 · Cited by 43
Brodsky, L., Wahed, A. S., Li, J., Tavis, J. E., Tsukahara, T., & Taylor, M. W. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000584 · Cited by 25
Spindler, K. R., Welton, A. R., Lim, E. S., Duvvuru, S., Althaus, I. W., Imperiale, J. E., Daoud, A. I., & Chesler, E. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903363 · Cited by 24
Cited by
Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway
Sun, L., Wu, J., Du, F., Chen, X., & Chen, Z. J. (2013) · Science · doi:10.1126/science.1232458 · Cited by 4,996
Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
Blanco-Melo, D., Nilsson-Payant, B. E., Liu, W.-C., Uhl, S., Hoagland, D., Møller, R., Jordan, T. X., Oishi, K., Panis, M., Sachs, D., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.026 · Cited by 4,222
Self-citationRegulation of type I interferon responses
Ivashkiv, L. B., & Donlin, L. T. (2014) · Nature Reviews Immunology · doi:10.1038/nri3581 · Cited by 3,297
Interferon-stimulated genes: A complex web of host defenses
Schneider, W. M., Chevillotte, M. D., & Rice, C. M. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120231 · Cited by 3,067
Self-citationMechanisms of SARS-CoV-2 entry into cells
Jackson, C. B., Farzan, M., Chen, B., & Choe, H. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00418-x · Cited by 3,022
Metadata
- Authors
- Schoggins, J. W., Wilson, S. J., Panis, M., Murphy, M. Y., Jones, C. T., Bieniasz, P., & Rice, C. M.
- Venue
- Nature
- Published
- 2011-04-10
- Volume
- 472
- Issue
- 7344
- Pages
- 481-485
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2078646756
- Cited by
- 2,433
- References
- 41
- FWCI
- 58.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.